[Results of surgical therapy of primary and recurrent retroperitoneal liposarcoma].
Between 1978 and 1994, 27 patients with a retroperitoneal liposarcoma underwent a total of 64 operations at our institution with a resectability rate of 96% of the primary and 100% of recurrent tumors. Operative morbidity (7.8%) and mortality (3.1%) were low, although multivisceral reactions were necessary in the majority of cases (73% of all primary tumors). The single most important prognostic factor was a potentially curative resection at first operation (5-year survival: RO: 75%, R1/R2: 34%), but also at first operation for tumor recurrence.
Hiller
W F
WF
Klinik für Abdominal- und Transplantationschirurgie, Medizinische Hochschule Hannover.
Jähne
J
J
Tusch
G
G
Meyer
H J
HJ
Pichlmayr
R
R
D000328:Adult; D000368:Aged; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008080:Liposarcoma / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D009367:Neoplasm Staging; D012186:Retroperitoneal Neoplasms / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D016019:Survival Analysis
Ergebnisse der operativen Therapie primärer und rezidivierender retroperitonealer Liposarkome.